Compare
OptimizeRx Corp vs Bridger Aerospace Group Holdings, Inc. vs DHI Group, Inc. vs SPAR Group, Inc.
| Latest fiscal year | OptimizeRx Corp OPRX | Bridger Aerospace Group Holdings, Inc. BAER | DHI Group, Inc. DHX | SPAR Group, Inc. SGRP |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $109.43M | $122.83M | $127.83M | $136.10M |
| Revenue growth (YoY) | +18.8% | +24.6% | -9.9% | -16.8% |
| Gross margin | 67.3% | 42.1% | 84.7% (computed) | 15.9% |
| Operating margin | 10.7% | n/a | -8.9% | -12.4% |
| Net margin | 4.7% | 3.4% | -10.6% | -18.1% |
| Net income | $5.13M | $4.14M | -$13.51M | -$24.63M |
| EPS (Diluted) | $0.27 | -$0.42 | -$0.30 | -$1.04 |
| Operating cash flow | $18.71M | $16.73M | $21.10M | -$18.44M |
| Free cash flow | $18.66M | -$64.21M | $13.79M | -$21.42M |
| Cash & equivalents | $23.36M | $31.38M | $2.91M | $3.26M |
| Total assets | $176.92M | $330.31M | $188.24M | $44.06M |
| Total liabilities | $48.62M | $265.64M | $93.74M | $43.44M |
| Shareholders' equity | $128.29M | -$342.59M | $94.51M | $622.0K |
| Return on year-end equity | 4.0% | n/a | -14.3% | n/m |
| Shares outstanding | 18.76M | 55.89M | 44.46M | 24.13M |
Revenue, most recent five fiscal years
| Fiscal year | OptimizeRx Corp | Bridger Aerospace Group Holdings, Inc. | DHI Group, Inc. | SPAR Group, Inc. |
|---|---|---|---|---|
| Latest | $109.43M Ended 2025-12-31 | $122.83M Ended 2025-12-31 | $127.83M Ended 2025-12-31 | $136.10M Ended 2025-12-31 |
| 1 year earlier | $92.13M Ended 2024-12-31 | $98.61M Ended 2024-12-31 | $141.93M Ended 2024-12-31 | $163.63M Ended 2024-12-31 |
| 2 years earlier | $71.52M Ended 2023-12-31 | $66.71M Ended 2023-12-31 | $151.88M Ended 2023-12-31 | $187.87M Ended 2023-12-31 |
| 3 years earlier | $62.45M Ended 2022-12-31 | $46.39M Ended 2022-12-31 | $149.68M Ended 2022-12-31 | $261.27M Ended 2022-12-31 |
| 4 years earlier | $61.29M Ended 2021-12-31 | n/a | $119.90M Ended 2021-12-31 | $255.72M Ended 2021-12-31 |